Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,350 GBX | +0.70% | +1.50% | +16.40% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.42% | 238B | |
+33.04% | 698B | |
+26.51% | 568B | |
-4.33% | 358B | |
+19.12% | 328B | |
+3.88% | 283B | |
+6.68% | 203B | |
-9.08% | 198B | |
+7.39% | 165B | |
-3.94% | 160B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Says FDA Accepts Datopotamab Deruxtecan's Biologics License Application for Review